FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Stephen Nicholls

Research Profile

Procedures

Ultrasonography, Interventional

Disorders

Physiology

Disease Progression

Chemicals & Drugs

Anatomy

Coronary Vessels

Concepts & Ideas

Co-author Network

Publications

TOP 3
Yu Kataoka; Steven E Nissen; Rishi Puri; Mingyuan Shao; E Murat Tuzcu; Kiyoko Uno; Kathy Wolski; Stephen J Nicholls
Multiple risk factor intervention and progression of coronary atherosclerosis in patients with type 2 diabetes mellitus.
Rishi Puri; E Murat Tuzcu; Kiyoko Uno; Kathy Wolski; Timothy D Crowe; Samir R Kapadia; Yu Kataoka; Karilane L King; Steven E Nissen; Stephen J Nicholls
Left main coronary atherosclerosis progression, constrictive remodeling, and clinical events.
Yu Kataoka; Joseph Martin; Stephen J Nicholls; Rishi Puri; James E Harvey; Samir R Kapadia; E Murat Tuzcu
Suspected hypersensitivity reaction following drug-eluting stent implantation. Novel insights with optical coherence tomography.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Stephen Nicholls (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Yu Kataoka; Steven E Nissen; Rishi Puri; Mingyuan Shao; E Murat Tuzcu; Kiyoko Uno; Kathy Wolski; Stephen J Nicholls
Multiple risk factor intervention and progression of coronary atherosclerosis in patients with type 2 diabetes mellitus.
European journal of preventive cardiology 2013;20(2):209-17.
2013: Rishi Puri; E Murat Tuzcu; Kiyoko Uno; Kathy Wolski; Timothy D Crowe; Samir R Kapadia; Yu Kataoka; Karilane L King; Steven E Nissen; Stephen J Nicholls
Left main coronary atherosclerosis progression, constrictive remodeling, and clinical events.
JACC. Cardiovascular interventions 2013;6(1):29-35.
2012: Yu Kataoka; Joseph Martin; Stephen J Nicholls; Rishi Puri; James E Harvey; Samir R Kapadia; E Murat Tuzcu
Suspected hypersensitivity reaction following drug-eluting stent implantation. Novel insights with optical coherence tomography.
JACC. Cardiovascular interventions 2012;5(7):e21-3.
2012: Rishi Puri; James E Harvey; Samir R Kapadia; Yu Kataoka; Stephen J Nicholls; E Murat Tuzcu
Optimizing outcomes during left main percutaneous coronary intervention with intravascular ultrasound and fractional flow reserve: the current state of evidence.
JACC. Cardiovascular interventions 2012;5(7):697-707.
2012: Stephen J Nicholls
The AIM-HIGH (Atherothrombosis Intervention in Metabolic Syndrome With Low HDL/High Triglycerides: Impact on Global Health Outcomes) trial: to believe or not to believe?
Journal of the American College of Cardiology 2012;59(23):2065-7.
2012: Rishi Puri; Kiyoko Uno; Yu Kataoka; Stephen J Nicholls
The distinctive nature of atherosclerotic vascular disease in diabetes: pathophysiological and morphological insights.
Current diabetes reports 2012;12(3):280-5.
2012: Stephen J Nicholls
Evacetrapib.
Current cardiology reports 2012;14(3):245-50.
2012: Yu Kataoka; Steven E Nissen; Rishi Puri; E Murat Tuzcu; Kiyoko Uno; Kathy Wolski; Stephen J Nicholls
Spotty calcification as a marker of accelerated progression of coronary atherosclerosis: insights from serial intravascular ultrasound.
Journal of the American College of Cardiology 2012;59(18):1592-7.
2012: Yu Kataoka; Rishi Puri; Kiyoko Uno; Stephen J Nicholls
Current imaging modalities for atherosclerosis.
Expert review of cardiovascular therapy 2012;10(4):457-71.
2012: Stephen J Nicholls; Kiyoko Uno
Peroxisome proliferator-activated receptor (PPAR α/γ) agonists as a potential target to reduce cardiovascular risk in diabetes.
Diabetes & vascular disease research : official journal of the International Society of Diabetes and Vascular Disease 2012;9(2):89-94.
2012: Stephen J Nicholls; Norman C Wong; Christie M Ballantyne; Philip J Barter; Marilyn R N Borgman; H Bryan Brewer; Allan Gordon; Jan Johannson; John J P Kastelein; Steven E Nissen
ApoA-I induction as a potential cardioprotective strategy: rationale for the SUSTAIN and ASSURE studies.
Cardiovascular drugs and therapy / sponsored by the International Society of Cardiovascular Pharmacotherapy 2012;26(2):181-7.
2012: Stephen J Nicholls; Robert S Rosenson; Gregory Schwartz; David D Waters; Dianna Bash; Matthew A Cavender; John J P Kastelein; Colin Hislop
Inhibition of secretory phospholipase A(2) in patients with acute coronary syndromes: rationale and design of the vascular inflammation suppression to treat acute coronary syndrome for 16 weeks (VISTA-16) trial.
Cardiovascular drugs and therapy / sponsored by the International Society of Cardiovascular Pharmacotherapy 2012;26(1):71-5.
2012: Rishi Puri; Kiyoko Uno; MyNgan Duong; Yu Kataoka; Stephen J Nicholls
The emerging role of plasma lipidomics in cardiovascular drug discovery.
Expert opinion on drug discovery 2012;7(1):63-72.
2011: Stephen J Nicholls; Joel S Raichlen; Kiyoko Uno; Kathy Wolski; Christie M Ballantyne; Philip J Barter; Marilyn Borgman; M John Chapman; Raimund M Erbel; Peter Libby; Steven E Nissen
Effect of two intensive statin regimens on progression of coronary disease.
The New England journal of medicine 2011;365(22):2078-87.
2011: Stephen J Nicholls
Apo a-I modulating therapies.
Current cardiology reports 2011;13(6):537-43.
2011: Stephen J Nicholls; Mingyuan Shao; Ming-Dauh Wang; H Bryan Brewer; Bo Hu; John J P Kastelein; Kathryn A Krueger; Ellen McErlean; Steven E Nissen
Effects of the CETP inhibitor evacetrapib administered as monotherapy or in combination with statins on HDL and LDL cholesterol: a randomized controlled trial.
JAMA : the journal of the American Medical Association 2011;306(19):2099-109.
2011: Stephen J Nicholls; Kiyoko Uno; Yu Kataoka
Clinical experience with rosuvastatin in the management of hyperlipidemia and the reduction of cardiovascular risk.
Expert review of cardiovascular therapy 2011;9(11):1383-90.
2011: Stephen J Nicholls
Will apoA-I-based therapies step up to cure coronary artery disease?
Expert review of cardiovascular therapy 2011;9(11):1367-70.
2011: Stephen J Nicholls; Marilyn Borgman; Steven E Nissen; Joel S Raichlen; Christie Ballantyne; Philip Barter; M John Chapman; Raimund Erbel; Peter Libby
Impact of statins on progression of atherosclerosis: rationale and design of SATURN (Study of Coronary Atheroma by InTravascular Ultrasound: effect of Rosuvastatin versus AtorvastatiN).
Current medical research and opinion 2011;27(6):1119-29.
2011: Stephen J Nicholls
Insights from a virtual world.
JACC. Cardiovascular interventions 2011;4(5):511-2.
2011: Ayman A Hussein; Kiyoko Uno; Kathy Wolski; Samir Kapadia; Paul Schoenhagen; E Murat Tuzcu; Steven E Nissen; Stephen J Nicholls
Peripheral arterial disease and progression of coronary atherosclerosis.
Journal of the American College of Cardiology 2011;57(10):1220-5.
2011: Stephen J Nicholls; Kiyoko Uno; Yu Kataoka; Steven E Nissen
ETC-216 for coronary artery disease.
Expert opinion on biological therapy 2011;11(3):387-94.
2011: Stephen J Nicholls; Allan Gordon; Jan Johansson; Kathy Wolski; Christie M Ballantyne; John J P Kastelein; Allen Taylor; Marilyn Borgman; Steven E Nissen
Efficacy and safety of a novel oral inducer of apolipoprotein a-I synthesis in statin-treated patients with stable coronary artery disease a randomized controlled trial.
Journal of the American College of Cardiology 2011;57(9):1111-9.
2011: Stephen J Nicholls; E Murat Tuzcu; Kathy Wolski; Ozgur Bayturan; Andrea Lavoie; Kiyoko Uno; Stuart Kupfer; Alfonso Perez; Richard Nesto; Steven E Nissen
Lowering the triglyceride/high-density lipoprotein cholesterol ratio is associated with the beneficial impact of pioglitazone on progression of coronary atherosclerosis in diabetic patients: insights from the PERISCOPE (Pioglitazone Effect on Regression of Intravascular Sonographic Coronary Obstruction Prospective Evaluation) study.
Journal of the American College of Cardiology 2011;57(2):153-9.
2011: W H Wilson Tang; Yuping Wu; Stephen J Nicholls; Stanley L Hazen
Plasma myeloperoxidase predicts incident cardiovascular risks in stable patients undergoing medical management for coronary artery disease.
Clinical chemistry 2011;57(1):33-9.
2010: Stephen J Nicholls; W H Wilson Tang; Heather Scoffone; Danielle M Brennan; Jaana Hartiala; Hooman Allayee; Stanley L Hazen
Lipoprotein(a) levels and long-term cardiovascular risk in the contemporary era of statin therapy.
Journal of lipid research 2010;51(10):3055-61.
2010: Stephen J Nicholls; Kiyoko Uno; E Murat Tuzcu; Steven E Nissen
Lessons from coronary intravascular ultrasound on the importance of raising high-density lipoprotein cholesterol.
Current atherosclerosis reports 2010;12(5):301-7.
2010: Ozgur Bayturan; Samir Kapadia; Stephen J Nicholls; E Murat Tuzcu; Mingyuan Shao; Kiyoko Uno; Ajai Shreevatsa; Andrea J Lavoie; Kathy Wolski; Paul Schoenhagen; Steven E Nissen
Clinical predictors of plaque progression despite very low levels of low-density lipoprotein cholesterol.
Journal of the American College of Cardiology 2010;55(24):2736-42.
2010: Ozgur Bayturan; E Murat Tuzcu; Kiyoko Uno; Andrea J Lavoie; Tingfei Hu; Ajai Shreevatsa; Kathy Wolski; Paul Schoenhagen; Samir Kapadia; Steven E Nissen; Stephen J Nicholls
Comparison of rates of progression of coronary atherosclerosis in patients with diabetes mellitus versus those with the metabolic syndrome.
The American journal of cardiology 2010;105(12):1735-9.
2010: Andrea J Lavoie; Ozgur Bayturan; Kiyoko Uno; Amy Hsu; Kathy Wolski; Paul Schoenhagen; Samir Kapadia; E Murat Tuzcu; Steven E Nissen; Stephen J Nicholls
Plaque progression in coronary arteries with minimal luminal obstruction in intravascular ultrasound atherosclerosis trials.
The American journal of cardiology 2010;105(12):1679-83.
2010: Kiyoko Uno; Stephen J Nicholls
Biomarkers of inflammation and oxidative stress in atherosclerosis.
Biomarkers in medicine 2010;4(3):361-73.
2010: Stephen J Nicholls; Amy Hsu; Kathy Wolski; Bo Hu; Ozgur Bayturan; Andrea Lavoie; Kiyoko Uno; E Murat Tuzcu; Steven E Nissen
Intravascular ultrasound-derived measures of coronary atherosclerotic plaque burden and clinical outcome.
Journal of the American College of Cardiology 2010;55(21):2399-407.
2010: Matthew A Cavender; Stephen J Nicholls; A Michael Lincoff
Strategies for the development of new PPAR agonists in diabetes.
European journal of cardiovascular prevention and rehabilitation : official journal of the European Society of Cardiology, Working Groups on Epidemiology & Prevention and Cardiac Rehabilitation and Exercise Physiology 2010;17 Suppl 1():S32-7.
2010: Stephen J Nicholls; Pia Lundman; Jean-Claude Tardif
Diabetic dyslipidemia: extending the target beyond LDL cholesterol.
European journal of cardiovascular prevention and rehabilitation : official journal of the European Society of Cardiology, Working Groups on Epidemiology & Prevention and Cardiac Rehabilitation and Exercise Physiology 2010;17 Suppl 1():S20-4.
2010: Ozgur Bayturan; E Murat Tuzcu; Andrea Lavoie; Tingfei Hu; Kathy Wolski; Paul Schoenhagen; Samir Kapadia; Steven E Nissen; Stephen J Nicholls
The metabolic syndrome, its component risk factors, and progression of coronary atherosclerosis.
Archives of internal medicine 2010;170(5):478-84.
2010: Andrea Lavoie; Kiyoko Uno; Ozgur Bayturan; Stephen J Nicholls
Findings of clinical trials that evaluate the impact of medical therapies on progression of atherosclerosis.
Current medical research and opinion 2010;26(3):745-51.
2010: Ozgur Bayturan; Kiyoko Uno; Andrea Lavoie; Stephen J Nicholls
Future requirement for arterial wall imaging modalities in the evaluation of novel anti-atherosclerotic therapies.
Current medical research and opinion 2010;26(3):753-7.
2010: Kiyoko Uno; Ozgur Bayturan; Andrea Lavoie; Stephen J Nicholls
Rationale and approach to evaluation of the impact of medical therapies on progression of atherosclerosis with arterial wall imaging.
Current medical research and opinion 2010;26(3):737-44.
2010: W H Wilson Tang; Yuping Wu; Stephen J Nicholls; Danielle M Brennan; Michael Pepoy; Shirley Mann; Alan Pratt; Frederick Van Lente; Stanley L Hazen
Subclinical myocardial necrosis and cardiovascular risk in stable patients undergoing elective cardiac evaluation.
Arteriosclerosis, thrombosis, and vascular biology 2010;30(3):634-40.
2010: Kiyoko Uno; Stephen J Nicholls
Statin effects on both low-density lipoproteins and high-density lipoproteins: is there a dual benefit?
Current atherosclerosis reports 2010;12(1):14-9.
2010: Ayman A Hussein; Stephen J Nicholls
Critical appraisal of laropiprant and extended-release niacin combination in the management of mixed dyslipidemias and primary hypercholesterolemia.
Therapeutics and clinical risk management 2010;6():183-90.
2010: Stephen J Nicholls; Gunnar Brandrup-Wognsen; Mike Palmer; Philip J Barter
Meta-analysis of comparative efficacy of increasing dose of Atorvastatin versus Rosuvastatin versus Simvastatin on lowering levels of atherogenic lipids (from VOYAGER).
The American journal of cardiology 2010;105(1):69-76.
2009: Stephen J Nicholls
Relationship between LDL, HDL, blood pressure and atheroma progression in the coronaries.
Current opinion in lipidology 2009;20(6):491-6.
2009: Stephen J Nicholls
High-density lipoprotein and progression rate of atherosclerosis in intravascular ultrasound trials.
The American journal of cardiology 2009;104(10 Suppl):16E-21E.
2009: MyNgan Duong; Stephen J Nicholls
Effect of lipid-modifying therapies on the functional quality of high-density lipoproteins: implications for drug development.
Expert opinion on drug discovery 2009;4(7):753-61.
2009: Ozgur Bayturan; E Murat Tuzcu; Stephen J Nicholls; Craig Balog; Andrea Lavoie; Kiyoko Uno; Tim Crowe; William A Magyar; Kathy Wolski; Samir Kapadia; Steven E Nissen; Paul Schoenhagen
Attenuated plaque at nonculprit lesions in patients enrolled in intravascular ultrasound atherosclerosis progression trials.
JACC. Cardiovascular interventions 2009;2(7):672-8.
2009: Stephen J Nicholls; Stanley L Hazen
Myeloperoxidase, modified lipoproteins, and atherogenesis.
Journal of lipid research 2009;50 Suppl():S346-51.
2009: Adnan K Chhatriwalla; Stephen J Nicholls; Thomas H Wang; Kathy Wolski; Ilke Sipahi; Tim Crowe; Paul Schoenhagen; Samir Kapadia; E Murat Tuzcu; Steven E Nissen
Low levels of low-density lipoprotein cholesterol and blood pressure and progression of coronary atherosclerosis.
Journal of the American College of Cardiology 2009;53(13):1110-5.
2009: John M Galla; Stephen J Nicholls
Pharmacologic therapy for coronary atherosclerosis in patients with Type 2 diabetes mellitus.
Expert review of cardiovascular therapy 2009;7(1):85-93.
2008: Stephen J Nicholls; E Murat Tuzcu; Danielle M Brennan; Jean-Claude Tardif; Steven E Nissen
Cholesteryl ester transfer protein inhibition, high-density lipoprotein raising, and progression of coronary atherosclerosis: insights from ILLUSTRATE (Investigation of Lipid Level Management Using Coronary Ultrasound to Assess Reduction of Atherosclerosis by CETP Inhibition and HDL Elevation).
Circulation 2008;118(24):2506-14.
2008: Stephen J Nicholls
The complex intersection of inflammation and oxidation: implications for atheroprotection.
Journal of the American College of Cardiology 2008;52(17):1379-80.
2008: Stephen J Nicholls
HDL: still a target for new therapies?
Current opinion in investigational drugs (London, England : 2000) 2008;9(9):950-6.
2008: Stephen J Nicholls
Rosuvastatin and progression of atherosclerosis.
Expert review of cardiovascular therapy 2008;6(7):925-33.
2008: Stephen J Nicholls; E Murat Tuzcu; Srinivasa Kalidindi; Kathy Wolski; Keon-W Moon; Ilke Sipahi; Paul Schoenhagen; Steven E Nissen
Effect of diabetes on progression of coronary atherosclerosis and arterial remodeling: a pooled analysis of 5 intravascular ultrasound trials.
Journal of the American College of Cardiology 2008;52(4):255-62.
2008: Stephen J Nicholls; E Murat Tuzcu
High-density lipoprotein and atheroma monitoring.
Current opinion in cardiology 2008;23(4):386-92.
2008: Steven E Nissen; Stephen J Nicholls; Kathy Wolski; Josep Rodés-Cabau; Christopher P Cannon; John E Deanfield; Jean-Pierre Després; John J P Kastelein; Steven R Steinhubl; Samir Kapadia; Muhammad Yasin; Witold Ruzyllo; Christophe Gaudin; Bernard Job; Bo Hu; Deepak L Bhatt; A Michael Lincoff; E Murat Tuzcu
Effect of rimonabant on progression of atherosclerosis in patients with abdominal obesity and coronary artery disease: the STRADIVARIUS randomized controlled trial.
JAMA : the journal of the American Medical Association 2008;299(13):1547-60.
2008: Steven E Nissen; Stephen J Nicholls; Kathy Wolski; Richard Nesto; Stuart Kupfer; Alfonso Perez; Horacio Jure; Robert De Larochellière; Cezar Staniloae; Kreton Mavromatis; Jacqueline Saw; Bo Hu; A Michael Lincoff; E Murat Tuzcu
Comparison of pioglitazone vs glimepiride on progression of coronary atherosclerosis in patients with type 2 diabetes: the PERISCOPE randomized controlled trial.
JAMA : the journal of the American Medical Association 2008;299(13):1561-73.
2008: Tamali Bhattacharyya; Stephen J Nicholls; Eric J Topol; Renliang Zhang; Xia Yang; David Schmitt; Xiaoming Fu; Mingyuan Shao; Danielle M Brennan; Stephen G Ellis; Marie-Luise Brennan; Hooman Allayee; Aldons J Lusis; Stanley L Hazen
Relationship of paraoxonase 1 (PON1) gene polymorphisms and functional activity with systemic oxidative stress and cardiovascular risk.
JAMA : the journal of the American Medical Association 2008;299(11):1265-76.
2008: Kellan E Ashley; John M Galla; Stephen J Nicholls
Brain natriuretic peptides as biomarkers for atherosclerosis.
Preventive cardiology 2008;11(3):172-6.
2007: Stephen J Nicholls; Zeneng Wang; Robert Koeth; Bruce Levison; Brian DelFraino; Vladimir Dzavik; Owen W Griffith; David Hathaway; Julio A Panza; Steven E Nissen; Judith S Hochman; Stanley L Hazen
Metabolic profiling of arginine and nitric oxide pathways predicts hemodynamic abnormalities and mortality in patients with cardiogenic shock after acute myocardial infarction.
Circulation 2007;116(20):2315-24.
2007: Stephen J Nicholls; E Murat Tuzcu; Steven E Nissen
Atherosclerosis regression: is low-density lipoprotein or high-density lipoprotein the answer?
Current atherosclerosis reports 2007;9(4):266-73.
2007: Zeneng Wang; Stephen J Nicholls; E Rene Rodriguez; Outi Kummu; Sohvi Hörkkö; John Barnard; Wanda F Reynolds; Eric J Topol; Joseph A DiDonato; Stanley L Hazen
Protein carbamylation links inflammation, smoking, uremia and atherogenesis.
Nature medicine 2007;13(10):1176-84.
2007: A Michael Lincoff; Kathy Wolski; Stephen J Nicholls; Steven E Nissen
Pioglitazone and risk of cardiovascular events in patients with type 2 diabetes mellitus: a meta-analysis of randomized trials.
JAMA : the journal of the American Medical Association 2007;298(10):1180-8.
2007: Stephen J Nicholls; Srinivasa Kalidindi; Keon-Woong Moon; Steven E Nissen
Atherosclerosis imaging in drug development.
Expert opinion on drug discovery 2007;2(9):1241-50.
2007: Stephen J Nicholls; Steven E Nissen
New targets of high-density lipoprotein therapy.
Current opinion in lipidology 2007;18(4):421-6.
2007: Ilke Sipahi; E Murat Tuzcu; Kathy Wolski; Stephen J Nicholls; Paul Schoenhagen; Bo Hu; Craig Balog; Mehdi H Shishehbor; William A Magyar; Tim Crowe; Samir Kapadia; Steven E Nissen
Beta-blockers and progression of coronary atherosclerosis: pooled analysis of 4 intravascular ultrasonography trials.
Annals of internal medicine 2007;147(1):10-8.
2007: Nezihi Baris; Ilke Sipahi; Samir R Kapadia; Stephen J Nicholls; Kursad Erinc; Okan Gulel; Tim Crowe; Robert Hobbs; Mohamad H Yamani; David O Taylor; Nicholas Smedira; Randall C Starling; Steven E Nissen; E Murat Tuzcu
Coronary angiography for follow-up of heart transplant recipients: insights from TIMI frame count and TIMI myocardial perfusion grade.
The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation 2007;26(6):593-7.
2007: S R Kalidindi; E M Tuzcu; Stephen J Nicholls
Role of imaging end points in atherosclerosis trials: focus on intravascular ultrasound.
International journal of clinical practice 2007;61(6):951-62.
2007: Stephen J Nicholls; Kathy Wolski; Ilke Sipahi; Paul Schoenhagen; Tim Crowe; Samir R Kapadia; Stanley L Hazen; E Murat Tuzcu; Steven E Nissen
Rate of progression of coronary atherosclerotic plaque in women.
Journal of the American College of Cardiology 2007;49(14):1546-51.
2007: Steven E Nissen; Jean-Claude Tardif; Stephen J Nicholls; James H Revkin; Charles L Shear; William T Duggan; Witold Ruzyllo; William B Bachinsky; Gabriel P Lasala; Gregory P Lasala; E Murat Tuzcu
Effect of torcetrapib on the progression of coronary atherosclerosis.
The New England journal of medicine 2007;356(13):1304-16.
2007: Steven E Nissen; Stephen J Nicholls; Kathy Wolski; Daniel C Howey; Ellen McErlean; Ming-Dauh Wang; Elisa V Gomez; John M Russo
Effects of a potent and selective PPAR-alpha agonist in patients with atherogenic dyslipidemia or hypercholesterolemia: two randomized controlled trials.
JAMA : the journal of the American Medical Association 2007;297(12):1362-73.
2007: Stephen J Nicholls; E Murat Tuzcu; Amy Hsu; Kathy Wolski; Ilke Sipahi; Paul Schoenhagen; Tim Crowe; Samir R Kapadia; Stanley L Hazen; Steven E Nissen
Comparison of coronary atherosclerotic volume in patients with glomerular filtration rates < or = 60 versus > 60 ml/min/1.73 m(2): a meta-analysis of intravascular ultrasound studies.
The American journal of cardiology 2007;99(6):813-6.
2007: Stephen J Nicholls; Adnan K Chhatriwalla; Pia Lundman
Impact of statins on atherosclerotic plaque.
Future cardiology 2007;3(2):157-64.
2007: Stephen J Nicholls; Jordan Andrews; Keon-Woong Moon
Exploring the natural history of atherosclerosis with intravascular ultrasound.
Expert review of cardiovascular therapy 2007;5(2):295-306.
2007: Stephen J Nicholls; E Murat Tuzcu; Ilke Sipahi; Adam W Grasso; Paul Schoenhagen; Tingfei Hu; Kathy Wolski; Tim Crowe; Milind Y Desai; Stanley L Hazen; Samir R Kapadia; Steven E Nissen
Statins, high-density lipoprotein cholesterol, and regression of coronary atherosclerosis.
JAMA : the journal of the American Medical Association 2007;297(5):499-508.
2007: Stephen J Nicholls; E Murat Tuzcu; Kathy Wolski; Ilke Sipahi; Paul Schoenhagen; Tim Crowe; Samir R Kapadia; Stanley L Hazen; Steven E Nissen
Coronary artery calcification and changes in atheroma burden in response to established medical therapies.
Journal of the American College of Cardiology 2007;49(2):263-70.
2006: Adnan K Chhatriwalla; Stephen J Nicholls; Steven E Nissen
The ASTEROID trial: coronary plaque regression with high-dose statin therapy.
Future cardiology 2006;2(6):651-4.
2006: Ilke Sipahi; E Murat Tuzcu; Paul Schoenhagen; Stephen J Nicholls; Michael S Chen; Tim Crowe; Aaron B Loyd; Samir Kapadia; Steven E Nissen
Paradoxical increase in lumen size during progression of coronary atherosclerosis: observations from the REVERSAL trial.
Atherosclerosis 2006;189(1):229-35.
2006: Ilke Sipahi; Stephen J Nicholls; E Murat Tuzcu; Steven E Nissen
Coronary atherosclerosis can regress with very intensive statin therapy.
Cleveland Clinic journal of medicine 2006;73(10):937-44.
2006: Ilke Sipahi; E Murat Tuzcu; Paul Schoenhagen; Stephen J Nicholls; Tim Crowe; Samir Kapadia; Steven E Nissen
Static and serial assessments of coronary arterial remodeling are discordant: an intravascular ultrasound analysis from the Reversal of Atherosclerosis with Aggressive Lipid Lowering (REVERSAL) trial.
American heart journal 2006;152(3):544-50.
2006: Ilke Sipahi; E Murat Tuzcu; Paul Schoenhagen; Kathy Wolski; Stephen J Nicholls; Craig Balog; Tim Crowe; Steven E Nissen
Effects of normal, pre-hypertensive, and hypertensive blood pressure levels on progression of coronary atherosclerosis.
Journal of the American College of Cardiology 2006;48(4):833-8.
2006: Stephen J Nicholls; Ilke Sipahi
Studying coronary plaque regression with IVUS.
Journal of interventional cardiology 2006;19(4):345.
2006: Stephen J Nicholls; E Murat Tuzcu; Ilke Sipahi; Paul Schoenhagen; Steven E Nissen
Intravascular ultrasound in cardiovascular medicine.
Circulation 2006;114(4):e55-9.
2006: Stephen J Nicholls; Ilke Sipahi; Paul Schoenhagen; Lisa Wisniewski; Tammy Churchill; Tim Crowe; Marlene Goormastic; Kathy Wolski; E Murat Tuzcu; Steven E Nissen
Intravascular ultrasound assessment of novel antiatherosclerotic therapies: rationale and design of the Acyl-CoA:Cholesterol Acyltransferase Intravascular Atherosclerosis Treatment Evaluation (ACTIVATE) Study.
American heart journal 2006;152(1):67-74.
2006: Ilke Sipahi; E Murat Tuzcu; Paul Schoenhagen; Stephen J Nicholls; Volkan Ozduran; Samir Kapadia; Steven E Nissen
Compensatory enlargement of human coronary arteries during progression of atherosclerosis is unrelated to atheroma burden: serial intravascular ultrasound observations from the REVERSAL trial.
European heart journal 2006;27(14):1664-70.
2006: Paul Schoenhagen; E Murat Tuzcu; Carolyn Apperson-Hansen; Chaohui Wang; Kathy Wolski; Songhua Lin; Ilke Sipahi; Stephen J Nicholls; William A Magyar; Aaron Loyd; Tammy Churchill; Tim Crowe; Steven E Nissen
Determinants of arterial wall remodeling during lipid-lowering therapy: serial intravascular ultrasound observations from the Reversal of Atherosclerosis with Aggressive Lipid Lowering Therapy (REVERSAL) trial.
Circulation 2006;113(24):2826-34.
2006: Stephen J Nicholls; E Murat Tuzcu; Ilke Sipahi; Paul Schoenhagen; Stanley L Hazen; Fady Ntanios; Chuan-Chuan Wun; Steven E Nissen
Effects of obesity on lipid-lowering, anti-inflammatory, and antiatherosclerotic benefits of atorvastatin or pravastatin in patients with coronary artery disease (from the REVERSAL Study).
The American journal of cardiology 2006;97(11):1553-7.
2006: Stephen J Nicholls; Ilke Sipahi; Paul Schoenhagen; Tim Crowe; E Murat Tuzcu; Steven E Nissen
Application of intravascular ultrasound in anti-atherosclerotic drug development.
Nature reviews. Drug discovery 2006;5(6):485-92.
2006: Stephen J Nicholls; E Murat Tuzcu; Tim Crowe; Ilke Sipahi; Paul Schoenhagen; Samir Kapadia; Stanley L Hazen; Chuan-Chuan Wun; Michele Norton; Fady Ntanios; Steven E Nissen
Relationship between cardiovascular risk factors and atherosclerotic disease burden measured by intravascular ultrasound.
Journal of the American College of Cardiology 2006;47(10):1967-75.
2006: Ilke Sipahi; Stephen J Nicholls; E Murat Tuzcu
Intravascular ultrasound in the current percutaneous coronary intervention era.
Cardiology clinics 2006;24(2):163-73, v.
2006: Steven E Nissen; Stephen J Nicholls; Ilke Sipahi; Peter Libby; Joel S Raichlen; Christie M Ballantyne; Jean Davignon; Raimund Erbel; Jean-Charles Fruchart; Jean-Claude Tardif; Paul Schoenhagen; Tim Crowe; Valerie A Cain; Kathy Wolski; Marlene Goormastic; E Murat Tuzcu
Effect of very high-intensity statin therapy on regression of coronary atherosclerosis: the ASTEROID trial.
JAMA : the journal of the American Medical Association 2006;295(13):1556-65.
2006: Steven E Nissen; E Murat Tuzcu; H Bryan Brewer; Ilke Sipahi; Stephen J Nicholls; Peter Ganz; Paul Schoenhagen; David D Waters; Carl J Pepine; Tim Crowe; Michael H Davidson; John E Deanfield; Lisa M Wisniewski; James J Hanyok; Laurent M Kassalow
Effect of ACAT inhibition on the progression of coronary atherosclerosis.
The New England journal of medicine 2006;354(12):1253-63.
2006: Stephen J Nicholls; E Murat Tuzcu; Ilke Sipahi; Paul Schoenhagen; Tim Crowe; Samir Kapadia; Steven E Nissen
Relationship between atheroma regression and change in lumen size after infusion of apolipoprotein A-I Milano.
Journal of the American College of Cardiology 2006;47(5):992-7.
2006: Stephen J Nicholls; Ilke Sipahi
Emerging role of intravascular ultrasound in the assessment of experimental anti-atherosclerotic therapies.
Current medicinal chemistry 2006;13(15):1727-34.
2006: Ilke Sipahi; Stephen J Nicholls; E Murat Tuzcu
Recent trends in coronary intravascular ultrasound: tracking atherosclerosis, pursuit of vulnerable plaques, and beyond.
Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology 2006;13(1):91-6.
2006: Stephen J Nicholls; Ilke Sipahi; E Murat Tuzcu
[Assessment of progression and regression of coronary atherosclerosis by intravascular ultrasound. A new paradigm shift?].
Revista española de cardiología 2006;59(1):57-66.
2005: Stephen J Nicholls; E Murat Tuzcu; Paul Schoenhagen; Ilke Sipahi; Tim Crowe; Samir Kapadia; Steven E Nissen
Effect of atorvastatin (80 mg/day) versus pravastatin (40 mg/day) on arterial remodeling at coronary branch points (from the REVERSAL study).
The American journal of cardiology 2005;96(12):1636-9.
2005: Stephen J Nicholls; Lemin Zheng; Stanley L Hazen
Formation of dysfunctional high-density lipoprotein by myeloperoxidase.
Trends in cardiovascular medicine 2005;15(6):212-9.
2005: Stephen J Nicholls; Stanley L Hazen
Myeloperoxidase and cardiovascular disease.
Arteriosclerosis, thrombosis, and vascular biology 2005;25(6):1102-11.
2005: Stephen J Nicholls; Zhongzhou Shen; Xiaoming Fu; Bruce Levison; Stanley L Hazen
Quantification of 3-nitrotyrosine levels using a benchtop ion trap mass spectrometry method.
Methods in enzymology 2005;396():245-66.
2004: Stephen J Nicholls; Stanley L Hazen
The role of myeloperoxidase in the pathogenesis of coronary artery disease.
Japanese journal of infectious diseases 2004;57(5):S21-2.